NRIX
Nurix Therapeutics, Inc.
$17.24+0.75 (4.55%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
Insider Activity
3 of 75 tradesExecutives investing their own money
🤖 AI InsightHaiku 4.5
Nurix Therapeutics, Inc. (NRIX) is a publicly traded company with 9 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 4 unique insiders. All recorded transactions were sales totaling $488K. Note that insider selling can occur for many reasons (diversification, tax planning, pre-scheduled 10b5-1 plans) and is not always a bearish signal. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 75 transactions (past 365 days)
| 2026-04-02 | 2026-04-02 | Ring Christine | CLO | Sale | 8,148 | $15.24 | $124,151 |
| 2026-03-03 | 2026-03-02 | Ring Christine | CLO | Sale | 8,148 | $15.44 | $125,797 |
| 2026-02-10 | 2026-02-10 | Van Houte Hans | CFO | Award | 93,750 | $0.00 | $0 |
| 2026-02-10 | 2026-02-10 | Ring Christine | CLO | Award | 93,750 | $0.00 | $0 |
| 2026-02-10 | 2026-02-10 | Hansen Gwenn | CSO | Award | 93,750 | $0.00 | $0 |
| 2026-02-10 | 2026-02-10 | Sands Arthur T | CEO | Award | 562,500 | $0.00 | $0 |
| 2026-02-09 | 2026-02-09 | Ring Christine | CLO | Sale | 14,261 | $16.66 | $237,617 |
| 2026-02-03 | 2026-02-03 | Hansen Gwenn | CSO | Exercise Conversion | 31,333 | $0.84 | $26,320 |
| 2026-02-03 | 2026-02-03 | Hansen Gwenn | CSO | Exercise Conversion | 31,333 | $0.00 | $0 |
| 2026-01-20 | 2026-01-20 | Ring Christine | CLO | Exercise Conversion | 3,760 | $1.86 | $6,994 |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.